Amarin (AMRN), FDA Enter REDUCE-IT SPA; Second Efficacy Analysis Added
Tweet Send to a Friend
Amarin Corporation plc (NASDAQ: AMRN) announced that the U.S. Food and Drug Administration (FDA) agreed to an amendment of the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE